Benjamin Graham fit · Defensive deep-value investing
Is United Therapeutics Corporation (UTHR) a Benjamin Graham Stock?
Meets 4/7 Graham criteria - classic deep-value candidate.
76/100
BLikely Graham stock
4/7 criteria passed
+10 sector-quality lift. Top-quintile within its sector on 5 of 5 quality metrics. Raw pillar score 66 → lifted to 76 before grade derivation.
Benjamin Graham's Criteria, Applied to UTHR
P/E ≤ 15
key19.2x
P/B ≤ 1.5
key4.2x
Current ratio ≥ 2
4.8x
Debt / Equity ≤ 1
0.0x
5y profitable
keyYes
Earnings yield ≥ 7%
5.2%
Revenue growing
17.2%
How UTHR Scores on Other Strategies
Live Financial Snapshot
Market cap
$22.46B
P/E (TTM)
19.2x
ROIC (TTM)
18.81%
Gross margin
86.58%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is UTHR's Benjamin Graham fit score?
UTHR scores 76/100 on our Benjamin Graham fit engine - grade B. Meets 4/7 Graham criteria - classic deep-value candidate.
Does Benjamin Graham actually own UTHR?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends UTHR.
How often is this score updated?
UTHR's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends UTHR.